Fluicell AB (publ) (STO:FLUI)
Sweden flag Sweden · Delayed Price · Currency is SEK
10.80
-0.40 (-3.57%)
At close: Mar 6, 2026

Fluicell AB Company Description

Fluicell AB (publ) operates as a life science company, provides platforms and research solutions for bioprinting and single-cell biology.

The company offers BIOPEN, a microfluidic platform for high-precision single-cell solution delivery that enables to control the cell microenvironment without moving or disturbing the cells; Biozone 6 that generate dose-response curves or study the effects of multiple drug compounds; and Dynaflow Resolve system, an ion channel screening platform, which allows to record various ion channel current in patch-clamp recording configuration.

It also provides Biopixlar, a 3D single-cell bioprinting platform that enables high cell viability and cell-to-cell communication; and Biopixlar AER, an easy-to-use 3D bioprinting platform that fits into your fume hood or biosafety cabinet.

The company also offers accessory and consumable products for bioprinting and single-cell biology. The company was incorporated in 2012 and is based in Mölndal, Sweden.

Fluicell AB (publ)
Country Sweden
Founded 2012
Industry Biotechnology
Sector Healthcare
Employees 11
CEO Carolina Trjulja

Contact Details

Address:
Flöjelbergsgatan 8C
Mölndal, 431 37
Sweden
Phone 46 7 62 08 33 54
Website fluicell.com

Stock Details

Ticker Symbol FLUI
Exchange Nasdaq Stockholm
Fiscal Year January - December
Reporting Currency SEK
ISIN Number SE0010831321
SIC Code 3845

Key Executives

Name Position
Carolina Trjulja Chief Executive Officer
Gavin D. M. Jeffries Co-Founder, Chief Technology Officer and Director
Joakim Wahlberg Chief Financial Officer
Jonas Hannestad Chief Marketing and Communications Officer